← Back to Search

Dietary Supplement

Low-dose bitter melon for Prediabetes

N/A
Waitlist Available
Research Sponsored by Midwest Center for Metabolic and Cardiovascular Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 12 weeks

Summary

This trial will study the effects of bitter melon on heart and metabolic health in people with prediabetes.

Eligible Conditions
  • Prediabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Body fat
Fasting glucose
Fasting insulin
+9 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Low-dose bitter melonExperimental Treatment1 Intervention
Subject will receive 1 Insumate bitter melon capsule/d (300 mg) and 1 placebo capsule/d (300 mg)
Group II: High-dose bitter melonExperimental Treatment1 Intervention
Subject will receive 2 Insumate bitter melon capsules/d (300 mg each)
Group III: PlaceboPlacebo Group1 Intervention
Subject will receive 2 placebo capsules/d (300 mg each)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low-dose bitter melon
2023
N/A
~80
High-dose bitter melon
2023
N/A
~80

Find a Location

Who is running the clinical trial?

Midwest Center for Metabolic and Cardiovascular ResearchLead Sponsor
21 Previous Clinical Trials
809 Total Patients Enrolled
Greenyn BiotechnologyUNKNOWN
Kevin C Maki, PhDStudy DirectorMB Clinical Research & Consulting
16 Previous Clinical Trials
889 Total Patients Enrolled
~27 spots leftby Nov 2025